As anti-abortion lawmakers threaten to risk a government shutdown unless Planned Parenthood is stripped of its federal funding, a new study illustrates the potentially disastrous effects of undermining the national women’s health organization.
By Marandah Field-Elliot, Government Relations Intern I have always been a paranoid person. A lock-the-doors-twice, never-even-think-of-trespassing, glass-of-water-between-drinks-at-a-party type of person. So, one Tuesday when I forgot to take my daily birth control until three hours past I was supposed to, I saw a life of teenage pregnancy flash before my eyes — my impending college Read more …
Hypoactive Sexual Desire Disorder (HSDD) is a serious condition experienced by about ten percent of pre-menopausal women, yet it has taken seven years for this drug, Flibanserin (Addyi), to get the green-light.
Access to healthcare is a fundamental human right. NOW will continue to work for a single-payer healthcare system — the common sense solution that would guarantee healthcare for all.
“It looks to me like there are more hurdles being put in front of this drug than there have been on drugs addressing male dysfunction,” Terry O’Neill, president of the National Organization for Women, told The Washington Post after flibanserin was rejected a second time. “Obviously, everyone only wants drugs to get on the market if they are proven safe and effective. But we don’t want attitudes to get in the way of a good drug.”
Tell the Senate to vote No on the SAVE America Act.